Pay in 4 interest-free payments of $5.06 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Approval was granted for adult obesity in 2021 for individuals with a BMI of 30 kg/m or 27 kg/m with comorbidities
We'll also settle in to contemplate and celebrate the power of creativity, art, and nature
CAS 2023788-19-2 MW 4813.45 g/mol Sequence Not listed Half-life Not listed Formula C225H348N48O68 Purity 99.55% Form Lyophilized powder Class Dual GIP/GLP-1 Receptor Agonist The dossier
First, rising obesity and type 2 diabetes prevalence is increasing the need for therapies that address weight and glucose together
5-Amino-1MQ and Related Metabolic Research Compounds Researchers sometimes compare 5-Amino-1MQ with other compounds involved in metabolic and obesity research, including: GLP-1 receptor agonists Tirzepatide Retatrutide Semaglutide Metabolic research peptides Interest in multi-pathway metabolic research continues expanding as researchers explore novel obesity and endocrine signaling mechanisms
US$ 27.16
US$ 26.60
US$ 22.25
US$ 23.89
US$ 29.51
US$ 20.93
US$ 21.62
US$ 23.80
US$ 27.81
